Connection
Robert McQueen to Antibodies, Anti-Idiotypic
This is a "connection" page, showing publications Robert McQueen has written about Antibodies, Anti-Idiotypic.
|
|
Connection Strength |
|
|
|
|
|
0.113 |
|
|
|
-
Campbell JD, McQueen RB, Briggs A. The "e" in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence. Ann Am Thorac Soc. 2014 Feb; 11 Suppl 2:S105-11.
Score: 0.113